Read the receipt.
- Displayed amount
- $198 /mo from; annual-plan terms
- Delivery route
- Injection
- Product status
- Compounded prescription
- Membership in this figure
- See provider inclusions and terms
- Quantity
- Confirm the exact supplied quantity
- Upfront commitment
- Confirm the initial charge and billing period
Confirm consultation, labs, shipping, supplies, cancellation and the complete initial invoice. Unspecified charges are not assumed to be zero.
Sources: Fridays — current plans, FDA — concerns with unapproved GLP-1 drugs
What this price means.
This is a promotional starting figure, not a verified cancel-anytime monthly invoice. The page contains several term and code choices. Obtain the selected term’s total, covered strengths, renewal and refund conditions in writing; do not assume that a headline discount extends to every prescription.
Sources: Fridays — current plans, FDA — concerns with unapproved GLP-1 drugs
The product context.
Zepbound is an FDA-approved tirzepatide medicine. Its approved uses and contraindications are defined in its prescribing information. A compounded preparation has not undergone FDA approval. Manufacturer offers for one device cannot be assumed to apply to another device or to every insurance situation.
Sources: Zepbound — prescribing information, FDA — concerns with unapproved GLP-1 drugs
Before you pay.
What will actually be charged today?
Confirm the initial charge and billing period. Request the full amount due today, its supply period, the next charge date and the renewal amount. The displayed price is a sourced offer, not a personalized invoice.
Is this a clinical recommendation?
No. This review covers public product and price information. Eligibility, treatment choice and the prescribed amount require an appropriate clinician. We have not tested this product.
What should I compare it with?
Start with the same ingredient, route, supplied quantity and billing term. Add any separate care or membership fees. Differences in product approval or formulation remain meaningful even when prices are similar.
Follow the evidence
Sources & price notes
Each source retains its own check date. Provider pages document advertised terms; they do not independently establish clinical outcomes.
- Fridays — current plans ↗
Rendered October 9: semaglutide from $99/month with annual-plan language and code FOREVER12; tirzepatide from $198 with code FOREVER500. Initial charge and full promotional conditions need confirmation.
Checked October 9, 2026
- FDA — concerns with unapproved GLP-1 drugs ↗
Safety, dosing errors, salt forms and misleading online marketing. Regulatory page rechecked October 9, 2026; retain distinctions between approval, risk information and compounding nominations.
Checked October 9, 2026
- Zepbound — prescribing information ↗
Approved uses, contraindications and warnings.
Checked October 8, 2026